Cidara Therapeutics, Inc. Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

CDTX

Clasificación en acciones #3185
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Precio por acción
$221.38
Última sincronización: 2026-01-08
Capitalización bursátil
$5.61B
Cambio (1 día)
0.00%
Cambio (1 año)
118.07%
País
US
Comercio Cidara Therapeutics, Inc. (CDTX)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Cidara Therapeutics, Inc. (CDTX)
La acción Cidara Therapeutics, Inc. (símbolo: CDTX) tuvo un total de 1 desdoblamientos.
El desdoblamiento más reciente ocurrió el Apr 24, 2024.
Una acción CDTX comprada antes de Apr 24, 2024 equivaldría hoy a 0.05 acciones CDTX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2024-04-24 1:20 x0.05 x0.05
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL